Protection against cephalosporin-induced lipid peroxidation and nephrotoxicity by (+)-cyanidanol-3 and vitamin E

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 6, 2007, Pages 867-875

  Cojocel, C ^a   Tolle, K L ^b   El Hajj, H ^a   Baumann, K ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Antioxidants; Cephalosporins; Glutathione depletion; Lipid peroxidation; Nephrotoxicity; Vitamin E

Indexed keywords

4 AMINOHIPPURIC ACID; ALKADIENE; ALPHA TOCOPHEROL; CATECHIN; CEFALORIDINE; CEFALOTIN; CEFOTAXIME; CEFOTIAM; CEPHALOSPORIN; GLUTATHIONE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN DETERMINATION; RAT; SINGLE DRUG DOSE;

RATTUS;

EID: 34347359561     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000600017     Document Type: Article

References (36)

1. Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents (first of three parts). N Engl J Med 1977; 296: 663-670.
2. Wachsmuth ED. Adaptation to nephrotoxic effects of cephaloridine in subacute rat toxicity studies. Toxicol Appl Pharmacol 1982; 63: 446-460.
3. Tune BM, Wu KY, Fravert D, Holtzman D. Effect of cephaloridine on respiration by renal cortical mitochondria. J Pharmacol Exp Ther 1979; 210: 98-100.
4. Cojocel C, Hannemann J, Baumann K. Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochim Biophys Acta 1985; 834: 402-410.
5. Kuo CH, Maita K, Sleight SD, Hook JB. Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol 1983; 67: 78-88.
6. Ullrich KJ. Renal transporters for organic anions and organic cations. Structural requirements for substrates. J Membr Biol 1997; 158: 95-107.
7. Khamdang S, Takeda M, Babu E, Noshiro R, Onozato ML, Tojo A, et al. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol 2003; 465: 1-7.
8. Uwai Y, Saito H, Inui K. Rat renal organic anion transporter rOAT1 mediates transport of urinary-excreted cephalosporins, but not of biliary-excreted cefoperazone. Drug Metab Pharmacokinet 2002; 17: 125-129.
9. Fujimoto K, Ohmura H, Kaneda T. Biological antioxidant activities of bromophenols and certain other antioxidants. Agric Boil Chem 1986; 50: 101-108.
10. Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 1983; 221:281-290.
11. Di Nola F. (+)-Cyanidanol-3 in acute viral hepatitis. Lancet 1980; 2:1379-1380.
12. Feher J, Blazovics A, Cornides A, Vereckei A. Effect of (+)-cyanidanol-3 on rat brain lipid peroxidation. Br J Exp Pathol 1985; 66: 161-164.
13. 2 formation and lipid peroxidation in liver microsomes. Res Commun Chem Pathol Pharmacol 1985; 47: 48-58.
14. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
15. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984; 105: 328-331.
16. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
17. Recknagel RO, Glande EA Jr. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984; 105: 331-337.
18. Netter KJ. A method for the direct measurement of O-demethylation in liver microsomes and its use in studying microsome inhibition by SKF-525-A. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1960; 238: 292-300.
19. Dent JG, Graichen ME, Schnell S, Lasker J. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats. A comparative study. Toxicol Appl Pharmacol 1980; 52: 45-53.
20. Cross RJ, Taggart JV. Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. Am J Physiol 1950; 161: 181-190.
21. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945; 25: 388-404.
22. Cojocel C. Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins. Arzneimittelforschung 1990; 40: 1140-1144.
23. Brogard JM, Arnaud JP, Blickle JF, Levy P, Domer M, Lautier F. Biliary elimination of cefotiam, an experimental and clinical study. Chemotherapy 1986; 32: 222-235.
24. Chamberlain J, Coombes JD, Dell D, Fromson JM, Ings RJ, MacDonald CM, et al. Metabolism of cefotaxime in animals and man. J Antimicrob Chemother 1980; 6 (Suppl A): 69-78.
25. Kuo CH, Hook JB. Depletion of renal glutathione content and nephretoxicity of cephaloridine in rabbits, rats, and mice. Toxicol Appl Pharmacol 1982; 63: 292-302.
26. Tune BM, Fravert D. Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloddine and cephaloglycin. Kidney Int 1980; 18: 591-600.
27. Draper HH, McGirr LG, Hadley M. The metabolism of malondialdehyde. Lipids 1986; 21: 305-307.
28. Mamett LJ, Buck J, Tuttle MA, Basu AK, Bull AW. Distribution and oxidation of malondialdehyde in mice. Prostaglandins 1985; 30: 241-254.
29. Goldstein RS, Pasino DA, Hewitt WR, Hook JB. Biochemical mechanisms of cephaloddine nephrotoxicity: time and concentration dependence of peroxidative injury. Toxicol Appl Pharmacol 1986; 83: 261-270.
30. Cojocel C, Laeschke KH, Inselmann G, Baumann K. Inhibition of cephaloridine-induced lipid peroxidation. Toxicology 1985; 35: 295-305.
31. Cojocel C, Thomson MS. Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport. Arch Toxicol 2004; 78: 525-532.
32. Fujimoto Y, Fujita T. Effect of lipid peroxidation on p-aminohippurate transport by rat kidney cortical slices. Br J Pharmacol 1982; 76: 373-379.
33. Jung KY, Takeda M, Shimoda M, Narikawa S, Tojo A, Kim DK, et al. Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci 2002; 70: 1861-1874.
34. Arreola-Mendoza L, Reyes JL, Melendez E, Martin D, Namorado MC, Sanchez E, et al. Alpha-tocopherol protects against the renal damage caused by potassium dichromate. Toxicology 2006; 218: 237-246.
35. Sugihara K, Gemba M. Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 1986; 40: 353-355.
36. Ajith TA, Usha S, Nivitha V. Ascorbic acid and alpha-tocopherol protect against anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chem Acta 2007 375: 82-86.